Lipid Droplet–Mitochondria Interactions: From Molecular Components to Spatial Aggregation Manipulation

Abstract

The aggregate form of interorganelle interaction is essential for the stable operation of cellular energy metabolism, signal transduction, as well as growth and development. Among these, the discovery of lipid droplet–mitochondria interactions (LDMIs) mediated by their aggregation has reshaped the understanding of how intracellular lipid metabolic networks operate within cells. Complex spatiotemporal interactions between lipid droplets and mitochondrial aggregates are commonly observed at the subcellular level, supporting the stable and efficient cycling of lipids and energy within the cell. Advanced techniques enabling organelle aggregation manipulation with high spatiotemporal precision have emerged as critical tools for investigating LDMIs and addressing diseases associated with LDMI dysregulation. This study aimed to summarize and update the distinctive characteristics of LDMIs and highlight the increasing understanding of their operational mechanisms, while also examining diseases caused by their dysfunction. Special emphasis was placed on the current challenges and prospects of strategies for the spatial aggregation manipulation of LDMIs, particularly the remarkable potential of optogenetic tools. With the continuous advancement of subcellular imaging and organelle aggregation manipulation technologies, LDMIs are poised to transform our understanding of cellular lipid metabolism networks and facilitate the effective manipulation of these complex networks at the organelle level.

Keywords

lipid droplet–mitochondria interactions / lipid metabolism network / membrane contact sites / optogenetic manipulation / organelle aggregation

References

[1] D. E. Gottschling and T. Nyström, “The Upsides and Downsides of Organelle Interconnectivity,” Cell 169 (2017): 24–34.

[2] T. Inoue, H. Maekawa, and R. Inagi, “Organelle Crosstalk in the Kidney,” Kidney International 95 (2019): 1318–1325.

[3] N. T. Boardman, G. Trani, M. Scalabrin, V. Romanello, and R. C. I. Wüst, “Intracellular to Interorgan Mitochondrial Communication in Striated Muscle in Health and Disease,” Endocrine Reviews 44 (2023): 668–692.

[4] A. S. Lyon, W. B. Peeples, and M. K. Rosen, “A Framework for Understanding the Functions of Biomolecular Condensates Across Scales,” Nature Reviews Molecular Cell Biology 22 (2021): 215–235.

[5] J. A. Olzmann and P. Carvalho, “Dynamics and Functions of Lipid Droplets,” Nature Reviews Molecular Cell Biology 20 (2019): 137–155.

[6] A. J. Mathiowetz and J. A. Olzmann, “Lipid Droplets and Cellular Lipid Flux,” Nature Cell Biology 26 (2024): 331–345.

[7] T. C. Walther and R. J. Farese, “Lipid Droplets and Cellular Lipid Metabolism,” Annual Review of Biochemistry 81 (2012): 687–714.

[8] L. Cui, A. H. Mirza, S. Zhang, B. Liang, and P. Liu, “Lipid Droplets and Mitochondria Are Anchored During Brown Adipocyte Differentiation,” Protein & Cell 10 (2019): 921–926.

[9] R. Zechner, R. Zimmermann, T. O. Eichmann, et al., “FAT SIGNALS—Lipases and Lipolysis in Lipid Metabolism and Signaling,” Cell Metabolism 15 (2012): 279–291.

[10] G. F. Grabner, H. Xie, M. Schweiger, and R. Zechner, “Lipolysis: Cellular Mechanisms for Lipid Mobilization From Fat Stores,” Nature Metabolism 3 (2021): 1445–1465.

[11] R. Liu, J. H. Lee, J. Li, et al., “Choline Kinase Alpha 2 Acts as a Protein Kinase to Promote Lipolysis of Lipid Droplets,” Molecular Cell 81 (2021): 2722–2735.e9.

[12] R. Singh, S. Kaushik, Y. Wang, et al., “Autophagy Regulates Lipid Metabolism,” Nature 458 (2009): 1131–1135.

[13] S. P. Metur and D. J. Klionsky, “SPART Links Autophagy Machinery and Lipid Droplets in Motor Neurons,” Autophagy 19 (2023): 2835–2836.

[14] A. Maestri, P. Garagnani, M. Pedrelli, C. E. Hagberg, P. Parini, and E. Ehrenborg, “Lipid Droplets, Autophagy, and Ageing: A Cell-Specific Tale,” Ageing Research Reviews 94 (2024): 102194.

[15] F. Klingelhuber, S. Frendo-Cumbo, M. Omar-Hmeadi, et al., “A Spatiotemporal Proteomic Map of human Adipogenesis,” Nature Metabolism 6 (2024): 861–879.

[16] V. Guyard, V. F. Monteiro-Cardoso, M. Omrane, et al., “ORP5 and ORP8 Orchestrate Lipid Droplet Biogenesis and Maintenance at ER–Mitochondria Contact Sites,” Journal of Cell Biology 221 (2022): e202112107.

[17] M. Piccolis, L. M. Bond, M. Kampmann, et al., “Probing the Global Cellular Responses to Lipotoxicity Caused by Saturated Fatty Acids,” Molecular Cell 74 (2019): 32–44.e8.

[18] C. Celik, S. Lee, W. S. Yap, and G. Thibault, “Endoplasmic Reticulum Stress and Lipids in Health and Diseases,” Progress in Lipid Research 89 (2023): 101198.

[19] B. Fromenty and M. Roden, “Mitochondrial Alterations in Fatty Liver Diseases,” Journal of Hepatology 78 (2023): 415–429.

[20] L. Enkler, V. Szentgyörgyi, M. Pennauer, et al., “Arf1 coordinates Fatty Acid Metabolism and Mitochondrial Homeostasis,” Nature Cell Biology 25 (2023): 1157–1172.

[21] A. Gemmink, S. Daemen, H. Kuijpers, et al., “Super-Resolution Microscopy Localizes Perilipin 5 at Lipid Droplet–Mitochondria Interaction Sites and at Lipid Droplets Juxtaposing to Perilipin 2,” Biochimica et Biophysica Acta (BBA)—Molecular and Cell Biology of Lipids 1863 (2018): 1423.

[22] I. Y. Benador, M. Veliova, K. Mahdaviani, et al., “Mitochondria Bound to Lipid Droplets Have Unique Bioenergetics, Composition, and Dynamics That Support Lipid Droplet Expansion,” Cell Metabolism 27 (2018): 869–885.e6.

[23] A. M. Valm, S. Cohen, W. R. Legant, et al., “Applying Systems-Level Spectral Imaging and Analysis to Reveal the Organelle Interactome,” Nature 546 (2017): 162–167.

[24] A. Capelo-Diz, S. Lachiondo-Ortega, D. Fernández-Ramos, et al., “Hepatic Levels of S-Adenosylmethionine Regulate the Adaptive Response to Fasting,” Cell Metabolism 35 (2023): 1373–1389.e8.

[25] G. E. Miner, C. M. So, W. Edwards, et al., “PLIN5 Interacts With FATP4 at Membrane Contact Sites to Promote Lipid Droplet-to-Mitochondria Fatty Acid Transport,” Developmental Cell 58 (2023): 1250–1265.e6.

[26] M. Boutant, S. S. Kulkarni, M. Joffraud, et al., “Mfn2 is Critical for Brown Adipose Tissue Thermogenic Function,” EMBO Journal 36 (2017): 1543–1558.

[27] Y. Meng, D. Guo, L. Lin, et al., “Glycolytic Enzyme PFKL Governs Lipolysis by Promoting Lipid Droplet–Mitochondria Tethering to Enhance β-Oxidation and Tumor Cell Proliferation,” Nature Metabolism 6 (2024): 1092–1107.

[28] M. E. de Almeida, N. Ortenblad, M. H. Petersen, et al., “Acute Exercise Increases the Contact Between Lipid Droplets and Mitochondria Independently of Obesity and Type 2 Diabetes,” Journal of Physiology 601 (2023): 1797–1815.

[29] Q. Ouyang, Q. Chen, S. Ke, et al., “Rab8a as a Mitochondrial Receptor for Lipid Droplets in Skeletal Muscle,” Developmental Cell 58 (2023): 289–305.e6.

[30] C. P. Najt, S. Adhikari, T. D. Heden, et al., “Organelle Interactions Compartmentalize Hepatic Fatty Acid Trafficking and Metabolism,” Cell Reports 42 (2023): 112435.

[31] A. D. Barbosa, D. B. Savage, and S. Siniossoglou, “Lipid Droplet–Organelle Interactions: Emerging Roles in Lipid Metabolism,” Current Opinion in Cell Biology 35 (2015): 91–97.

[32] A. D. Barbosa and S. Siniossoglou, “Function of Lipid Droplet-Organelle Interactions in Lipid Homeostasis,” Biochimica et Biophysica Acta (BBA)—Molecular Cell Research 1864 (2017): 1459–1468.

[33] I. Y. Benador, M. Veliova, M. Liesa, and O. S. Shirihai, “Mitochondria Bound to Lipid Droplets: Where Mitochondrial Dynamics Regulate Lipid Storage and Utilization,” Cell Metabolism 29 (2019): 827–835.

[34] L. J. Wang, X. H. Lai, Z. Luo, G. L. Feng, and Y. F. Song, “Diallyl Disulfide Alleviates Hepatic Steatosis by the Conservative Mechanism From Fish to Tetrapod: Augment Mfn2/Atgl-Mediated Lipid Droplet-mitochondria Coupling,” Redox Biology 77 (2024): 103395.

[35] Z. Hong, J. Adlakha, N. Wan, et al., “Mitoguardin-2-Mediated Lipid Transfer Preserves Mitochondrial Morphology and Lipid Droplet Formation,” Journal of Cell Biology 221 (2022): e202207022.

[36] J. Wang, N. Fang, J. Xiong, Y. Du, Y. Cao, and W. K. Ji, “An ESCRT-Dependent Step in Fatty Acid Transfer From Lipid Droplets to Mitochondria Through VPS13D−TSG101 Interactions,” Nature Communications 12 (2021): 1252.

[37] H. Yoon, J. L. Shaw, M. C. Haigis, and A. Greka, “Lipid Metabolism in Sickness and in Health: Emerging Regulators of Lipotoxicity,” Molecular Cell 81 (2021): 3708–3730.

[38] S. A. Baker and J. Rutter, “Metabolites as Signalling Molecules,” Nature Reviews Molecular Cell Biology 24 (2023): 355–374.

[39] H. Fan and Y. Tan, “Lipid Droplet–Mitochondria Contacts in Health and Disease,” International Journal of Molecular Sciences 25 (2024): 6878.

[40] J. C. Bórquez, F. Díaz-Castro, F. P.-D. La Fuente, et al., “Mitofusin-2 Induced by Exercise Modifies Lipid Droplet-Mitochondria Communication, Promoting Fatty Acid Oxidation in Male Mice With NAFLD,” Metabolism 152 (2024): 155765.

[41] L. Che, J. Huang, J. X. Lin, et al., “Aflatoxin B1 Exposure Triggers Hepatic Lipotoxicity via p53 and Perilipin 2 Interaction-Mediated Mitochondria-Lipid Droplet Contacts: An in Vitro and in Vivo Assessment,” Journal of Hazardous Materials 445 (2023): 130584.

[42] V. I. Gallardo-Montejano, C. Yang, L. Hahner, et al., “Perilipin 5 Links Mitochondrial Uncoupled Respiration in Brown Fat to Healthy White Fat Remodeling and Systemic Glucose Tolerance,” Nature Communications 12 (2021): 3320.

[43] S. Louzoun-Zada, Q. Z. Jaber, and M. Fridman, “Guiding Drugs to Target-Harboring Organelles: Stretching Drug-Delivery to a Higher Level of Resolution,” Angewandte Chemie International Edition 58 (2019): 15584–15594.

[44] J. Hu, Y. Liu, Y. Du, X. Peng, and Z. Liu, “Cellular Organelles as Drug Carriers for Disease Treatment,” Journal of Controlled Release 363 (2023): 114–135.

[45] X. Shao, C. Meng, W. Song, T. Zhang, and Q. Chen, “Subcellular Visualization: Organelle-Specific Targeted Drug Delivery and Discovery,” Advanced Drug Delivery Reviews 199 (2023): 114977.

[46] Z. Fang and H. Chen, “The in Vivo Drug Delivery Pattern of the Organelle-Targeting Small Molecules,” Advanced Drug Delivery Reviews 200 (2023): 115020.

[47] Y. Shin, J. Berry, N. Pannucci, M. P. Haataja, J. E. Toettcher, and C. P. Brangwynne, “Spatiotemporal Control of Intracellular Phase Transitions Using Light-Activated optoDroplets,” Cell 168 (2017): 159–171.e14.

[48] B. Chen, M. Cui, Y. Wang, P. Shi, H. Wang, and F. Wang, “Recent Advances in Cellular Optogenetics for Photomedicine,” Advanced Drug Delivery Reviews 188 (2022): 114457.

[49] S. Y. Lee, J. S. Cheah, B. Zhao, et al., “Engineered Allostery in Light-Regulated LOV-Turbo Enables Precise Spatiotemporal Control of Proximity Labeling in Living Cells,” Nature Methods 20 (2023): 908–917.

[50] W. A. Prinz, A. Toulmay, and T. Balla, “The Functional Universe of Membrane Contact Sites,” Nature Reviews Molecular Cell Biology 21 (2020): 7–24.

[51] H. Wu, P. Carvalho, and G. K. Voeltz, “Here, There, and Everywhere: The Importance of ER Membrane Contact Sites,” Science 361 (2018): eaan5835.

[52] D. Naón, M. I. Hernández-Alvarez, S. Shinjo, et al., “Splice Variants of Mitofusin 2 Shape the Endoplasmic Reticulum and Tether It to Mitochondria,” Science 380 (2023): h9351.

[53] L. Scorrano, M. A. De Matteis, S. Emr, et al., “Coming Together to Define Membrane Contact Sites,” Nature Communications 10 (2019): 1287.

[54] A. J. Brownstein, M. Veliova, R. Acin-Perez, et al., “Mitochondria Isolated From Lipid Droplets of White Adipose Tissue Reveal Functional Differences Based on Lipid Droplet Size,” Life Science Alliance 7 (2024): e202301934.

[55] M. Eisenberg-Bord, N. Shai, M. Schuldiner, and M. Bohnert, “A Tether Is a Tether Is a Tether: Tethering at Membrane Contact Sites,” Developmental Cell 39 (2016): 395–409.

[56] S. Muallem, W. Y. Chung, A. Jha, and M. Ahuja, “Lipids at Membrane Contact Sites: Cell Signaling and Ion Transport,” EMBO Reports 18 (2017): 1893–1904.

[57] M. Veliova, A. Petcherski, M. Liesa, and O. S. Shirihai, “The Biology of Lipid Droplet-Bound Mitochondria,” Seminars in Cell & Developmental Biology 108 (2020): 55–64.

[58] M. Giacomello, A. Pyakurel, C. Glytsou, and L. Scorrano, “The Cell Biology of Mitochondrial Membrane Dynamics,” Nature Reviews Molecular Cell Biology 21 (2020): 204–224.

[59] A. Margiotta, “Membrane Fusion and SNAREs: Interaction With Ras Proteins,” International Journal of Molecular Sciences 23 (2022): 8067.

[60] R. Jahn, D. C. Cafiso, and L. K. Tamm, “Mechanisms of SNARE Proteins in Membrane Fusion,” Nature Reviews Molecular Cell Biology 25 (2024): 101–118.

[61] G. K. Voeltz, E. M. Sawyer, G. Hajnóczky, and W. A. Prinz, “Making the Connection: How Membrane Contact Sites Have Changed Our View of Organelle Biology,” Cell 187 (2024): 257–270.

[62] M. Schuldiner and M. Bohnert, “A Different Kind of Love—Lipid Droplet Contact Sites,” Biochimica et Biophysica Acta (BBA)—Molecular and Cell Biology of Lipids 1862 (2017): 1188–1196.

[63] R. Rakotonirina-Ricquebourg, V. Costa, and V. Teixeira, “Hello From the Other Side: Membrane Contact of Lipid Droplets With Other Organelles and Subsequent Functional Implications,” Progress in Lipid Research 85 (2022): 101141.

[64] C. Freyre, P. C. Rauher, C. S. Ejsing, and R. W. Klemm, “MIGA2 Links Mitochondria, the ER, and Lipid Droplets and Promotes De Novo Lipogenesis in Adipocytes,” Molecular Cell 76 (2019): 811–825.e14.

[65] L. Hu, D. Tang, B. Qi, et al., “Mfn2/Hsc70 Complex Mediates the Formation of Mitochondria-Lipid Droplets Membrane Contact and Regulates Myocardial Lipid Metabolism,” Advanced Science 11 (2024): e2307749.

[66] S. L. Reck-Peterson, W. B. Redwine, R. D. Vale, and A. P. Carter, “The Cytoplasmic Dynein Transport Machinery and Its Many Cargoes,” Nature Reviews Molecular Cell Biology 19 (2018): 382–398.

[67] V. T. Tang and D. Ginsburg, “Cargo Selection in Endoplasmic Reticulum–to–Golgi Transport and Relevant Diseases,” Journal of Clinical Investigation 133 (2023): e163838.

[68] B. Kien, S. Kolleritsch, N. Kunowska, et al., “Lipid Droplet–Mitochondria Coupling via perilipin 5 Augments Respiratory Capacity but Is Dispensable for FA Oxidation,” Journal of Lipid Research 63 (2022): 100172.

[69] T. Klecker, R. J. Braun, and B. Westermann, “Lipid Droplets Guard Mitochondria During Autophagy,” Developmental Cell 42 (2017): 1–2.

[70] A. R. Thiam and I. Dugail, “Lipid Droplet–Membrane Contact Sites—From Protein Binding to Function,” Journal of Cell Science 132 (2019): jcs230169.

[71] I. Gordaliza-Alaguero, C. Cantó, and A. Zorzano, “Metabolic Implications of Organelle–Mitochondria Communication,” EMBO Reports 20 (2019): e47928.

[72] T. C. Walther, J. Chung, and R. J. Farese, “Lipid Droplet Biogenesis,” Annual Review of Cell and Developmental Biology 33 (2017): 491–510.

[73] A. Zadoorian, X. Du, and H. Yang, “Lipid Droplet Biogenesis and Functions in Health and Disease,” Nature Reviews Endocrinology 19 (2023): 443–459.

[74] X. Zhang, W. Xu, R. Xu, et al., “Plin5 Bidirectionally Regulates Lipid Metabolism in Oxidative Tissues,” Oxidative Medicine and Cellular Longevity 2022 (2022): 4594956.

[75] S. Kolleritsch, B. Kien, G. Schoiswohl, et al., “Low Cardiac Lipolysis Reduces Mitochondrial Fission and Prevents Lipotoxic Heart Dysfunction in Perilipin 5 Mutant Mice,” Cardiovascular Research 116 (2020): 339.

[76] S. N. Keenan, W. De Nardo, J. Lou, et al., “Perilipin 5 S155 Phosphorylation by PKA Is Required for the Control of Hepatic Lipid Metabolism and Glycemic Control,” Journal of Lipid Research 62 (2021): 100016.

[77] M. A. Sanders, F. Madoux, L. Mladenovic, et al., “Endogenous and Synthetic ABHD5 Ligands Regulate ABHD5-Perilipin Interactions and Lipolysis in Fat and Muscle,” Cell Metabolism 22 (2015): 851–860.

[78] M. Varghese, V. A. Kimler, F. R. Ghazi, et al., “Adipocyte Lipolysis Affects Perilipin 5 and Cristae Organization at the Cardiac Lipid Droplet-mitochondrial Interface,” Scientific Reports 9 (2019): 4734.

[79] X. Gao, L. Jian, L. Zhang, et al., “Perilipin 5 Protects the Mitochondrial Oxidative Functions and Improves the Alcoholic Liver Injury in Mice,” Liver International 44 (2024): 357–369.

[80] T. J. Melia and K. M. Reinisch, “A Possible Role for VPS13-Family Proteins in Bulk Lipid Transfer, Membrane Expansion and Organelle Biogenesis,” Journal of Cell Science 135 (2022): jcs259357.

[81] J. A. Lees and K. M. Reinisch, “Inter-organelle Lipid Transfer: A Channel Model for Vps13 and Chorein-N Motif Proteins,” Current Opinion in Cell Biology 65 (2020): 66–71.

[82] S. W. Suzuki, M. West, Y. Zhang, et al., “A Role for Vps13-Mediated Lipid Transfer at the ER–Endosome Contact Site in ESCRT-mediated Sorting,” Journal of Cell Biology 223 (2024): e202307094.

[83] N. Kumar, M. Leonzino, W. Hancock-Cerutti, et al., “VPS13A and VPS13C Are Lipid Transport Proteins Differentially Localized at ER Contact Sites,” Journal of Cell Biology 217 (2018): 3625–3639.

[84] S. K. Dziurdzik and E. Conibear, “The Vps13 Family of Lipid Transporters and Its Role at Membrane Contact Sites,” International Journal of Molecular Sciences 22 (2021): 2905.

[85] J. Adlakha, Z. Hong, P. Li, and K. M. Reinisch, “Structural and Biochemical Insights Into Lipid Transport by VPS13 Proteins,” Journal of Cell Biology 221 (2022): e202202030.

[86] L. Xu, X. Wang, J. Zhou, et al., “Miga-mediated Endoplasmic Reticulum–mitochondria Contact Sites Regulate Neuronal Homeostasis,” eLife 9 (2020): e56584.

[87] H. Kim, S. Lee, Y. Jun, and C. Lee, “Structural Basis for Mitoguardin-2 Mediated Lipid Transport at ER-mitochondrial Membrane Contact Sites,” Nature Communications 13 (2022): 3702.

[88] G. N. Dorn, “Mitofusins as Mitochondrial Anchors and Tethers,” Journal of Molecular and Cellular Cardiology 142 (2020): 146–153.

[89] N. Yapa, V. Lisnyak, B. Reljic, and M. T. Ryan, “Mitochondrial Dynamics in Health and Disease,” FEBS Letters 595 (2021): 1184–1204.

[90] M. Conte, C. Franceschi, M. Sandri, and S. Salvioli, “Perilipin 2 and Age-Related Metabolic Diseases: A New Perspective,” Trends in Endocrinology & Metabolism 27 (2016): 893–903.

[91] A. Gemmink, S. Daemen, B. Brouwers, et al., “Decoration of Myocellular Lipid Droplets With Perilipins as a Marker for in Vivo Lipid Droplet Dynamics: A Super-Resolution Microscopy Study in Trained Athletes and Insulin Resistant Individuals,” Biochimica et Biophysica Acta (BBA)—Molecular and Cell Biology of Lipids 1866 (2021): 158852.

[92] J. M. Kohlmayr, G. F. Grabner, A. Nusser, et al., “Mutational Scanning Pinpoints Distinct Binding Sites of Key ATGL Regulators in Lipolysis,” Nature Communications 15 (2024): 2516.

[93] A. S. Rambold, S. Cohen, and J. Lippincott-Schwartz, “Fatty Acid Trafficking in Starved Cells: Regulation by Lipid Droplet Lipolysis, Autophagy, and Mitochondrial Fusion Dynamics,” Developmental Cell 32 (2015): 678–692.

[94] S. C. Wu, Y. M. Lo, J. H. Lee, et al., “Stomatin Modulates Adipogenesis Through the ERK Pathway and Regulates Fatty Acid Uptake and Lipid Droplet Growth,” Nature Communications 13 (2022): 4174.

[95] W. Li, P. He, Y. Huang, et al., “Selective Autophagy of Intracellular Organelles: Recent Research Advances,” Theranostics 11 (2021): 222–256.

[96] R. M. de la Rosa, L. Deng, A. Gemmink, et al., “Hypoxia-Inducible Lipid Droplet-Associated Induces DGAT1 and Promotes Lipid Storage in Hepatocytes,” Molecular Metabolism 47 (2021): 101168.

[97] H. Kang, H. Lee, K. Kim, et al., “DGKB Mediates Radioresistance by Regulating DGAT1-Dependent Lipotoxicity in Glioblastoma,” Cell Reports Medicine 4 (2023): 100880.

[98] T. B. Nguyen, S. M. Louie, J. R. Daniele, et al., “DGAT1-Dependent Lipid Droplet Biogenesis Protects Mitochondrial Function During Starvation-Induced Autophagy,” Developmental Cell 42 (2017): 9–21.e5.

[99] L. Kong, Q. Bai, C. Li, et al., “Molecular Probes for Tracking Lipid Droplet Membrane Dynamics,” Nature Communications 15 (2024): 9413.

[100] M. Long, A. Sanchez-Martinez, M. Longo, et al., “DGAT1 Activity Synchronises With Mitophagy to Protect Cells From Metabolic Rewiring by Iron Depletion,” EMBO Journal 41 (2022): e109390.

[101] M. Long and T. G. Mcwilliams, “Lipid Droplets Promote Efficient Mitophagy,” Autophagy 19 (2023): 724–725.

[102] M. Pan, C. Zorbas, M. Sugaya, et al., “Glutamine Deficiency in Solid Tumor Cells Confers Resistance to Ribosomal RNA Synthesis Inhibitors,” Nature Communications 13 (2022): 3706.

[103] N. Koundouros and G. Poulogiannis, “Reprogramming of Fatty Acid Metabolism in Cancer,” British Journal of Cancer 122 (2020): 4–22.

[104] M. Martin-Perez, U. Urdiroz-Urricelqui, C. Bigas, and S. A. Benitah, “The Role of Lipids in Cancer Progression and Metastasis,” Cell Metabolism 34 (2022): 1675–1699.

[105] X. Bian, R. Liu, Y. Meng, D. Xing, D. Xu, and Z. Lu, “Lipid Metabolism and Cancer,” Journal of Experimental Medicine 218 (2021): e20201606.

[106] M. Han, E. A. Bushong, M. Segawa, et al., “Spatial Mapping of Mitochondrial Networks and Bioenergetics in Lung Cancer,” Nature 615 (2023): 712–719.

[107] J. Borén, M. R. Taskinen, E. Björnson, and C. J. Packard, “Metabolism of Triglyceride-Rich Lipoproteins in Health and Dyslipidaemia,” Nature Reviews Cardiology 19 (2022): 577–592.

[108] C. Marx, “Lipid Metabolism Disorders,” Deutsches Ärzteblatt International 119 (2022): 229.

[109] M. Lytrivi, A. L. Castell, V. Poitout, and M. Cnop, “Recent Insights Into Mechanisms of β-Cell Lipo- and Glucolipotoxicity in Type 2 Diabetes,” Journal of Molecular Biology 432 (2020): 1514–1534.

[110] Z. Chen, Z. X. Jin, J. Cai, et al., “Energy Substrate Metabolism and Oxidative Stress in Metabolic Cardiomyopathy,” Journal of Molecular Medicine 100 (2022): 1721–1739.

[111] A. Römer, T. Linn, and S. F. Petry, “Lipotoxic Impairment of Mitochondrial Function in β-Cells: A Review,” Antioxidants 10 (2021): 293.

[112] B. Morant-Ferrando, D. Jimenez-Blasco, P. Alonso-Batan, et al., “Fatty Acid Oxidation Organizes Mitochondrial Supercomplexes to Sustain Astrocytic ROS and Cognition,” Nature Metabolism 5 (2023): 1290–1302.

[113] Y. Wu, H. Luo, Z. Pan, W. Chen, and L. Bi, “AXL Tyrosine Kinase Inhibitor TP-0903 Induces ROS Trigger Neuroblastoma Cell Apoptosis via Targeting the miR-335-3p/DKK1 Expression,” Cell Death Discovery 12 (2025): 13.

[114] Y. Cheng, S. Shao, Z. Wang, et al., “From Lipotoxicity to Pan-Lipotoxicity,” Cell Discovery 11 (2025): 27.

[115] Z. Z. Chen and R. E. Gerszten, “Metabolomics and Proteomics in Type 2 Diabetes,” Circulation Research 126 (2020): 1613–1627.

[116] S. N. Keenan, R. C. Meex, J. Lo, et al., “Perilipin 5 Deletion in Hepatocytes Remodels Lipid Metabolism and Causes Hepatic Insulin Resistance in Mice,” Diabetes 68 (2019): 543–555.

[117] C. Wang, Y. Yuan, J. Wu, et al., “Plin5 deficiency Exacerbates Pressure Overload-induced Cardiac Hypertrophy and Heart Failure by Enhancing Myocardial Fatty Acid Oxidation and Oxidative Stress,” Free Radical Biology and Medicine 141 (2019): 372–382.

[118] Y. Li, M. K. Torp, F. Norheim, et al., “Isolated Plin5-Deficient Cardiomyocytes Store Less Lipid Droplets Than Normal, but Without Increased Sensitivity to Hypoxia,” Biochimica et Biophysica Acta (BBA)—Molecular and Cell Biology of Lipids 1866 (2021): 158873.

[119] Q. Wu, M. Zhao, X. He, et al., “Acetylcholine Reduces Palmitate-Induced Cardiomyocyte Apoptosis by Promoting Lipid Droplet Lipolysis and perilipin 5-mediated Lipid Droplet–Mitochondria Interaction,” Cell Cycle 20 (2021): 1890–1906.

[120] S. L. Friedman, B. A. Neuschwander-Tetri, M. Rinella, and A. J. Sanyal, “Mechanisms of NAFLD Development and Therapeutic Strategies,” Nature Medicine 24 (2018): 908–922.

[121] D. Q. Huang, H. B. El-Serag, and R. Loomba, “Global Epidemiology of NAFLD-Related HCC: Trends, Predictions, Risk Factors and Prevention,” Nature Reviews Gastroenterology & Hepatology 18 (2021): 223–238.

[122] N. Mendez-Sanchez, V. C. Cruz-Ramon, O. L. Ramirez-Perez, J. P. Hwang, B. Barranco-Fragoso, and J. Cordova-Gallardo, “New Aspects of Lipotoxicity in Nonalcoholic Steatohepatitis,” International Journal of Molecular Sciences 19 (2018): 2034.

[123] X. Xu, J. Qiu, X. Li, et al., “Perilipin5 Protects Against Non-Alcoholic Steatohepatitis by Increasing 11-Dodecenoic Acid and Inhibiting the Occurrence of Ferroptosis,” Nutrition & Metabolism 20 (2023): 29.

[124] N. Shatz, Y. Chohan, and D. J. Klionsky, “ATG14 and STX18: Gatekeepers of Lipid Droplet Degradation and the Implications for Disease Modulation,” Autophagy 20 (2024): 1697–1699.

[125] V. Sorrentino, M. Romani, L. Mouchiroud, et al., “Enhancing Mitochondrial Proteostasis Reduces Amyloid-β Proteotoxicity,” Nature 552 (2017): 187–193.

[126] Y. Li, D. Munoz-Mayorga, Y. Nie, et al., “Microglial Lipid Droplet Accumulation in Tauopathy Brain Is Regulated by Neuronal AMPK,” Cell Metabolism 36 (2024): 1351–1370.e8.

[127] M. S. Haney, R. Pálovics, C. N. Munson, et al., “APOE4/4 is Linked to Damaging Lipid Droplets in Alzheimer's Disease Microglia,” Nature 628 (2024): 154–161.

[128] G. Qi, Y. Mi, X. Shi, H. Gu, R. D. Brinton, and F. Yin, “ApoE4 Impairs Neuron-Astrocyte Coupling of Fatty Acid Metabolism,” Cell Reports 34 (2021): 108572.

[129] J. A. Pradeepkiran and P. H. Reddy, “Defective Mitophagy in Alzheimer's Disease,” Ageing Research Reviews 64 (2020): 101191.

[130] M. Zyśk, C. Beretta, L. Naia, et al., “Amyloid-β Accumulation in Human Astrocytes Induces Mitochondrial Disruption and Changed Energy Metabolism,” Journal of Neuroinflammation 20 (2023): 43.

[131] C. Zhang, H. Shao, J. Zhang, et al., “Long-Term Live-Cell Lipid Droplet-Targeted Biosensor Development for Nanoscopic Tracking of Lipid Droplet–Mitochondria Contact Sites,” Theranostics 11 (2021): 7767–7778.

[132] Q. Chen, H. Fang, X. Shao, et al., “A Dual-Labeling Probe to Track Functional Mitochondria–lysosome Interactions in Live Cells,” Nature Communications 11 (2020): 6290.

[133] Y. Song, P. Huang, X. Liu, et al., “Light-Inducible Deformation of Mitochondria in Live Cells,” Cell Chemical Biology 29 (2022): 109–119.e3.

[134] K. Qiu, W. Zou, H. Fang, et al., “Light-Activated Mitochondrial Fission Through Optogenetic Control of Mitochondria–Lysosome Contacts,” Nature Communications 13 (2022): 4303.

[135] A. D. Vlasova, S. M. Bukhalovich, D. F. Bagaeva, et al., “Intracellular Microbial Rhodopsin-Based Optogenetics to Control Metabolism and Cell Signaling,” Chemical Society Reviews 53 (2024): 3327–3349.

[136] P. Tan, L. He, Y. Huang, and Y. Zhou, “Optophysiology: Illuminating Cell Physiology With Optogenetics,” Physiological Reviews 102 (2022): 1263–1325.

[137] S. W. Wang, C. Gao, Y. M. Zheng, et al., “Current Applications and Future Perspective of CRISPR/Cas9 Gene Editing in Cancer,” Molecular Cancer 21 (2022): 57.

[138] H. Chen, B. Ding, P. Ma, and J. Lin, “Recent Progress in Upconversion Nanomaterials for Emerging Optical Biological Applications,” Advanced Drug Delivery Reviews 188 (2022): 114414.

[139] Z. Zhang, Y. Chen, and Y. Zhang, “Self-Assembly of Upconversion Nanoparticles Based Materials and Their Emerging Applications,” Small 18 (2022): e2103241.

[140] W. Zhang, W. Zheng, P. Huang, D. Yang, Z. Shao, and X. Chen, “The marriage of perovskite nanocrystals with lanthanide-doped upconversion nanoparticles for advanced optoelectronic applications,” Aggregate 5 (2024): e558.

[141] J. Alvelid, M. Damenti, C. Sgattoni, and I. Testa, “Event-Triggered STED Imaging,” Nature Methods 19 (2022): 1268–1275.

[142] R. F. Laine, H. S. Heil, S. Coelho, et al., “High-Fidelity 3D Live-Cell Nanoscopy Through Data-Driven Enhanced Super-Resolution Radial Fluctuation,” Nature Methods 20 (2023): 1949–1956.

[143] R. Chen, X. Tang, Y. Zhao, et al., “Single-Frame Deep-Learning Super-Resolution Microscopy for Intracellular Dynamics Imaging,” Nature Communications 14 (2023): 2854.

[144] T. Calì and M. Brini, “Quantification of Organelle Contact Sites by Split-GFP-Based Contact Site Sensors (SPLICS) in Living Cells,” Nature Protocols 16 (2021): 5287–5308.

[145] S. P. Laptenok, A. A. Gil, C. R. Hall, et al., “Infrared Spectroscopy Reveals Multi-Step Multi-Timescale Photoactivation in the Photoconvertible Protein Archetype Dronpa,” Nature Chemistry 10 (2018): 845–852.

[146] Y. Hu, X. Gao, J. Ma, et al., “New AIE Emitters from the Unexpected Boron Tribromide/Boron Trichloride-mediated Cyclization Reaction and Application for Fluorescence Imaging of Lipid Droplets,” Aggregate 6 (2025): e735.

[147] S. F. Banani, H. O. Lee, A. A. Hyman, and M. K. Rosen, “Biomolecular Condensates: Organizers of Cellular Biochemistry,” Nature Reviews Molecular Cell Biology 18 (2017): 285–298.

[148] H. Guo, W. Wan, Y. Huang, et al., “LipoID profiles lipid droplet interactions and identifies interorganelle regulators,” Nature Chemical Biology (2026), https://doi.org/10.1038/s41589-025-02127-4.

[149] M. Zhou, B. Kong, X. Zhang, et al., “A Proximity Labeling Strategy Enables Proteomic Analysis of Inter-organelle Membrane Contacts,” iScience 26 (2023): 107159.

[150] J. Qu, G. Luo, S. Li, et al., “Label-Free In Vivo Monitoring of Lipid Droplets for Real-Time Evaluation of Anticancer Drugs,” Analytical Chemistry 96 (2024): 2754–2758.

[151] L. Barazzuol, T. Tykhonenko, T. L. Griffiths, A. Vagnoni, M. Brini, and T. Calì, “Tracking Spatiotemporal Distribution of Organelle Contacts in Vivo With SPLICS Reporters,” Cell Death & Disease 16 (2025): 210.

[152] L. Qiao, L. Niu, M. Wang, et al., “A Sensitive Red/Far-Red Photoswitch for Controllable Gene Therapy in Mouse Models of Metabolic Diseases,” Nature Communications 15 (2024): 10310.

Rights & permissions

2026 The Author(s). Aggregate published by SCUT, AIEI, and John Wiley & Sons Australia, Ltd.